Treatment of Chronic Myeloid Leukemia According to Current Guidelines: The Results of the Pilot Prospective Study “Early Induction Therapy and Monitoring” (РИТМ)
Background. Current clinical guidelines on diagnosis and treatment of chronic myeloid leukemia (CML) define indications for substitution of first-line tyrosine kinase inhibitor (TKI) at therapy failure during different phases of disease progression. Aim. To assess the efficacy of CML treatment with...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Practical Medicine Publishing House
2019-03-01
|
Series: | Kliničeskaâ onkogematologiâ |
Subjects: | |
Online Access: |
http://bloodjournal.ru/wp-content/uploads/2019/03/10.pdf
|